Managed Healthcare ExecutiveOpinion

Predictions for 2026 from Alexa B. D’Angelo, Ph.D., M.P.H. and Jeremiah Johnson

Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...